MilliporeSigma receives the industry's first EXCiPACT certification for cell culture media manufacturing

Ibex Medical Analytics achieves notable milestones with its AI-first approach to cancer diagnostics

Albertsons Companies pharmacies now offer COVID and flu vaccines to help protect communities this respiratory virus season

OmniSYS rebrands as XiFin Pharmacy Solutions, launches Pharmacy Payor Rate Transparency Monitor, and earns the Pharmacy 500 Award

Gilead’s Livdelzi (Seladelpar) receives FDA accelerated approval for primary biliary cholangitis

ProJenX announces the formation of its Clinical Advisory Board

Citius Pharmaceuticals' LYMPHIR™ wins FDA approval for relapsed/refractory cutaneous T-cell lymphoma

NewAmsterdam Pharma announces positive topline data from the Phase 3 BROOKLYN trial of Obicetrapib in heterozygous familial hypercholesterolemia patients

Cygnus Technologies and TriLink BioTechnologies® collaborate to launch AccuRes™ Host Cell DNA Quantification Kits

Neurocrine Biosciences Launches INGREZZA® SPRINKLE (valbenazine) Capsules.

Updated flu and COVID-19 vaccinations are now available at CVS Pharmacy® and MinuteClinic

$FDA Grants Second Approval for EPKINLY® (epcoritamab-bysp) to Treat Relapsed or Refractory Follicular Lymphoma$

FDA Grants Second Approval for EPKINLY® (epcoritamab-bysp) to Treat Relapsed or Refractory Follicular Lymphoma

Featured Press Releases

Theralogix Introduces Berberine Enhanced Absorption

Cognito Therapeutics Presents Spectris™ Data on Brain Structural Maintenance in Alzheimer’s at AD/PD™ 2025

02 Apr 2025

Cognito Therapeutics, a pioneering neurotechnology company developing disease-modifying therapies...

Coya Therapeutics Announces Results from an Investigator-Initiated Study Showing Treg Enhancement and Cognitive Stability in Frontotemporal Dementia Patients Treated with Low-Dose IL-2 and CTLA4-Ig

OCuSOFT Inc. introduces Retaine® Omega Forté™, a liquid supplement designed to deliver superior nutritional support in the management of dry eye

Seegene Expands Its AMR Testing Portfolio in Europe with the Launch of the Allplex™ MDRO Assay Under IVDR

European Commission Approves AbbVie's TEPKINLY® (epcoritamab) in Combination with Lenalidomide and Rituximab for the Treatment of Relapsed or Refractory Follicular Lymphoma

Twist Bioscience Launched MRD Express for Faster Turnaround

By Twist Bioscience Corporation
Twist Bioscience Corporation
29 Oct 2026

Sciensus Appoints James Tugendhat OBE as Its Chief Executive Officer

By Sciensus
Sciensus
29 Oct 2026

KODAK PHARMACEUTICALS Expands Its Portfolio and Launches an Online Store in the U.S

By Eastman Kodak Company
Eastman Kodak Company
29 Oct 2026

Alchemy 21/12 Introduces Oleotide™, a Breakthrough Modular Biotechnology Platform for Advanced Skincare

By Alchemy 21/12
Alchemy 21/12
28 Oct 2026

CELSET Launches Korean Botulinum Toxin Type A Brand SOLTOX in International Markets

By CELSET INC
CELSET INC
28 Oct 2026

SEKISUI Diagnostics Announces 510(k) Clearance and Launches the OSOM® COVID-19/Flu A&B Combo Test

By SEKISUI DIAGNOSTICS, LLC
SEKISUI DIAGNOSTICS, LLC
27 Oct 2026

Most Popular

Dallas-Based Microbiome Brand resbiotic® Comes Home to Texas with Launch at H-E-B

By Resbiotic Nutrition, Inc.

Aug 03
At the PHPN 2025 Symposium, Corsair Pharma will present new data on its proprietary transdermal system for Treprostinil prodrug

By Corsair Pharma

Sep 15
The merger with NLS Pharmaceutics was approved by Kadimastem shareholders

By NLS Pharmaceutics Ltd.; Kadimastem Ltd.

Jan 29

October 2026

M	T	W	T	F	S	S
			1	2	3	4
5	6	7	8	9	10	11
12	13	14	15	16	17	18
19	20	21	22	23	24	25
26	27	28	29	30	31

Search your requirement

Social media

MilliporeSigma receives the industry's first EXCiPACT certification for cell culture media manufacturing

Ibex Medical Analytics achieves notable milestones with its AI-first approach to cancer diagnostics

Albertsons Companies pharmacies now offer COVID and flu vaccines to help protect communities this respiratory virus season

OmniSYS rebrands as XiFin Pharmacy Solutions, launches Pharmacy Payor Rate Transparency Monitor, and earns the Pharmacy 500 Award

Gilead’s Livdelzi (Seladelpar) receives FDA accelerated approval for primary biliary cholangitis

ProJenX announces the formation of its Clinical Advisory Board

Citius Pharmaceuticals' LYMPHIR™ wins FDA approval for relapsed/refractory cutaneous T-cell lymphoma

NewAmsterdam Pharma announces positive topline data from the Phase 3 BROOKLYN trial of Obicetrapib in heterozygous familial hypercholesterolemia patients

Cygnus Technologies and TriLink BioTechnologies® collaborate to launch AccuRes™ Host Cell DNA Quantification Kits

Neurocrine Biosciences Launches INGREZZA® SPRINKLE (valbenazine) Capsules.

Updated flu and COVID-19 vaccinations are now available at CVS Pharmacy® and MinuteClinic

FDA Grants Second Approval for EPKINLY® (epcoritamab-bysp) to Treat Relapsed or Refractory Follicular Lymphoma

Featured Press Releases

Theralogix Introduces Berberine Enhanced Absorption

Cognito Therapeutics Presents Spectris™ Data on Brain Structural Maintenance in Alzheimer’s at AD/PD™ 2025

Coya Therapeutics Announces Results from an Investigator-Initiated Study Showing Treg Enhancement and Cognitive Stability in Frontotemporal Dementia Patients Treated with Low-Dose IL-2 and CTLA4-Ig

OCuSOFT Inc. introduces Retaine® Omega Forté™, a liquid supplement designed to deliver superior nutritional support in the management of dry eye

Seegene Expands Its AMR Testing Portfolio in Europe with the Launch of the Allplex™ MDRO Assay Under IVDR

European Commission Approves AbbVie's TEPKINLY® (epcoritamab) in Combination with Lenalidomide and Rituximab for the Treatment of Relapsed or Refractory Follicular Lymphoma

Twist Bioscience Launched MRD Express for Faster Turnaround

Sciensus Appoints James Tugendhat OBE as Its Chief Executive Officer

KODAK PHARMACEUTICALS Expands Its Portfolio and Launches an Online Store in the U.S

Alchemy 21/12 Introduces Oleotide™, a Breakthrough Modular Biotechnology Platform for Advanced Skincare

CELSET Launches Korean Botulinum Toxin Type A Brand SOLTOX in International Markets

SEKISUI Diagnostics Announces 510(k) Clearance and Launches the OSOM® COVID-19/Flu A&B Combo Test

Most Popular

Dallas-Based Microbiome Brand resbiotic® Comes Home to Texas with Launch at H-E-B

At the PHPN 2025 Symposium, Corsair Pharma will present new data on its proprietary transdermal system for Treprostinil prodrug

The merger with NLS Pharmaceutics was approved by Kadimastem shareholders

User Area

Discover

Engage with Us

Search your requirement

Social media

Featured Press Releases

Most Popular

User Area

Discover

Engage with Us

Subscribe to Our Monthly Newsletter